By Abiola Olawale
The Nigeria Centre for Disease Control and Prevention (NCDC) has announced that active medical surveillance for 62 individuals identified as contacts of an imported Ebola Virus Disease (EVD) case is scheduled to conclude on November 13, 2026.
The containment operation follows the confirmation of an imported Ebola case on October 20, 2026, involving a 42-year-old Ugandan woman—the wife of a Swiss diplomat—who arrived in Abuja earlier in the month. Diagnostic testing confirmed the infection was caused by the Bundibugyo strain of the virus, a rarer species for which there is currently no specifically approved vaccine or antiviral treatment.
The index patient was evacuated to Switzerland for specialized medical care on October 26, alongside her husband. To prevent localized transmission, public health officials instituted comprehensive contact tracing across affected areas.
The NCDC, in its latest Ebola Disease Situation Report, said: “Sixty-Two (62) contacts” had been identified, adding that “Contacts are expected to complete follow-up by November. Expected completion dates range from 31 Oct to 13 Nov 2026.”
The development indicates that November 13 is the latest projected date for completing the monitoring of all contacts currently identified in connection with the confirmed case, although surveillance and contact-tracing activities remain ongoing.
It said contact tracing and monitoring were continuing, while additional contact tracers had been mapped and trained to strengthen surveillance.
The agency also disclosed plans to “engage and assess additional contacts for possible evacuation to the quarantine facility” and “continue follow-up of contacts in quarantine.”
It added that a high-level stakeholder meeting had been held with partner agencies to strengthen coordination, resource mobilisation and accountability in the response.
Among its next steps, the NCDC listed the continuation of coordination across One Health sectors and partners, implementation of the Incident Action Plan and strengthened preparedness in states considered at high risk.
On laboratory investigations, the agency disclosed that 18 samples had been tested since the outbreak was confirmed, with one positive result and 17 negative results.
It stated that the positive sample was from the index case, while the 17 negative samples comprised 15 collected from contacts of the confirmed patient and two from suspected cases.
The report said, “Laboratory confirmation reported on 20th October 2026,” adding that “Phylogenetic sequencing concluded by NCDC NRL & The African Centre of Excellence for Genomics of Infectious Diseases (ACEGID).”
It said the scope and strategy for identifying contacts had been reviewed and expanded, while the case definitions for Ebola disease had also been reviewed to improve the identification and management of suspected infections.
The report further listed plans to review guidelines on contact tracing, self-quarantine, self-care kits and the Ebola call protocol, as well as develop an Ebola disease dashboard on the Surveillance Outbreak Response Management and Analysis System, SORMAS, to improve contact management.
On coordination, the NCDC said the National Incident Management System had been activated under the leadership of the Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate.
It said the implementation of prioritised response activities had continued across thematic areas, while the Incident Action Plan had been finalised.
It also disclosed that standard operating procedures and job aids had been validated for sample reception, molecular detection and genomic sequencing.
The Agency said it would maintain uninterrupted Ebola testing and confirmation at the National Reference Laboratory, with plans to expand testing capacity to Lagos.
It also listed the need to maintain diagnostic testing and laboratory records, share reports of genomic sequencing conducted on the confirmed case sample, and pre-position additional laboratory reagents and commodities across the national network of laboratories.
The Agency also noted that an inspection and assessment of the isolation centre had been conducted and that the medical evacuation of the index case had been supervised, with measures taken to protect healthcare workers.
Among its next steps, the NCDC said it would review and disseminate approved procedures and guidelines covering triage, isolation, supportive care, psychosocial support and discharge.
It also planned to establish referral mechanisms for suspected cases, from the point of detection to designated treatment centres, while identifying and optimising treatment facilities in states with designated points of entry.


